Agmatine Administration Effects on Equine Gastric Ulceration and Lameness
Open Access
- 8 December 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (24) , 7283
Abstract
Osteoarthritis (OA) accounts for up to 60% of equine lameness. Agmatine, a decarboxylated arginine, may be a viable option for OA management, based on reports of its analgesic properties. Six adult thoroughbred horses, with lameness attributable to thoracic limb OA, received either daily oral phenylbutazone (6.6 mg/kg), agmatine sulfate (25 mg/kg) or a control for 30 days, with 21-day washout periods between treatments. Subjective lameness, thoracic limb ground reaction forces (GRF), plasma agmatine and agmatine metabolite levels were evaluated using an established rubric, a force platform, and mass spectrometry, respectively, before, during and after each treatment period. Gastric ulceration and plasma chemistries were evaluated before and after treatments. Braking GRFs were greater after 14 and 29 days of agmatine compared to phenylbutazone administration. After 14 days of phenylbutazone administration, vertical GRFs were greater than for agmatine or the control. Glandular mucosal ulcer scores were lower after agmatine than phenylbutazone administration. Agmatine plasma levels peaked between 30 and 60 min and were largely undetectable by 24 h after oral administration. In contrast, plasma citric acid levels increased throughout agmatine administration, representing a shift in the metabolomic profile. Agmatine may be a viable option to improve thoracic limb GRFs while reducing the risk of glandular gastric ulceration in horses with OA.Keywords
Funding Information
- Tynewald Foundation (USDA 1443)
- Louisiana State University (USDA 1443)
- United States Department of Agriculture (USDA 1443)
This publication has 71 references indexed in Scilit:
- Agmatine: clinical applications after 100 years in translationDrug Discovery Today, 2013
- Agmatine induces gastric protection against ischemic injury by reducing vascular permeability in ratsWorld Journal of Gastroenterology, 2012
- The use of phenylbutazone in the horseJournal of Veterinary Pharmacology and Therapeutics, 2011
- Non-steroidal anti-inflammatory drugs for neuropathic pain: How do we explain continued widespread use?Pain, 2009
- Influence of different head‐neck positions on vertical ground reaction forces, linear and time parameters in the unridden horse walking and trotting on a treadmillEquine Veterinary Journal, 2009
- Repeated immobilization stress alters rat hippocampal and prefrontal cortical morphology in parallel with endogenous agmatine and arginine decarboxylase levelsNeurochemistry International, 2008
- Arginine metabolism and nutrition in growth, health and diseaseAmino Acids, 2008
- Equine osteoarthritis: a brief review of the disease and its causesEquine and Comparative Exercise Physiology, 2004
- Inducible nitric oxide expression in equine articular chondrocytes: effects of antiinflammatory compoundsOsteoarthritis and Cartilage, 2002
- Suppression of inducible nitric oxide generation by agmatine aldehyde: Beneficial effects in sepsisJournal of Cellular Physiology, 2001